Jennie Ge

Trained as enzymologist. Worked in the pharmaceutical/biotech companies since 2004, in the area of oncology and immuno-oncology small molecule drug discovery. Targets worked on include Hsp90, Bcl-2 (protein-protein interaction), FAAH, KRas G12C, and various kinases. Currently at Blueprint Medicines.